Targeted biological therapies for Graves’ disease and thyroid-associated ophthalmopathy. Focus on B-cell depletion with Rituximab - Hegedüs, L; Smith, T J; Douglas, R S; Nielsen, C H (Clin Endocrinol (Oxf), 2011)